Preparing to move forward with new Missions

2018-04-26T15:37:01+00:00 Apr. 11, 2018 9:17AM EST|

When companies navigate the regulatory process the contrast between fast paced businesses and bureaucrats can be like the Clash of the Titans.

One such example is Kraig Biocraft Laboratories (OTCQB: KBLB), the only peer-reviewed developer of spider silk based fibers.  As a small company with a big biotechnology breakthrough, Kraig Labs has been working on setting up production in Vietnam

Not content to sit back and wait, Kraig Labs established a new R&D facility to help better position for what it hopes to be the world’s first large scale production run of recombinant spider silk, a super fiber with many potential high tech applications ranging from anti-ballistic clothing to medical, including artificial skin and scaffolding for artificial ligaments.

Today, Kraig Labs introduced its new hybrid spider silkworm cocoons, which are estimated to be twice as heavy as the cocoons they were producing just four months ago and such help it commercialize some of the toughest natural fibers for almost the same cost as normal every day silk.

With other efforts in the spider silk space reportedly raising over $300 million, in combined funding to produce synthetic silks, interest in the various technologies continues to grow, so Kraig Labs posted a technology and cost analysis at www.kraiglabs.com/comparison.

The week kicked off with the Wall Street Journal reporting that the Justice Department would approve the proposed $66 billion mega-merger of Bayer (XE: BAYN) and Monsanto (NYSE: MON) "after the companies pledged to sell off additional assets," which is believed to be the final regulatory hurdle in the U.S.

Once combined, the new agrichemical business will be better positioned to take on the other recently merged competitors, like Dow and DuPont.

Connect with 24/7 Market News on social mediahttps://twitter.com/247MarketNewsHQ

https://www.facebook.com/247MarketNewsHQ/

About 24/7 Market News

As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information.  24/7 MN provides comprehensive corporate communications resources and tools to engage the investment community.

DISCLAIMER:

24/7 Market News (24/7MN) is a third party publisher and news dissemination service provider that produces regular sponsored and non-sponsored reports, articles, stock market blogs, and newsletters covering equities listed on the NYSE, NASDAQ and micro-cap exchanges. 24/7MN holds no investment licenses and is NOT a financial advisory firm, investment adviser, analyst, or broker-dealer and does not undertake any activities that would require such registration. 24/7MN's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.

24/7MN has covered Kraig Biocraft Laboratories, Inc. in the past and owns shares. You may view this as a conflict of interest. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and based on publicly available information which is believed to be reliable. 24/7MN makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice.   24/7MN and/or its affiliates are not responsible for any gains or losses that result from the opinions expressed and are not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.

For further information on 24/7 Market News, please go to www.247marketnews.com

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan," or "planned," "will," or "should," "expected," "anticipates," "draft," "eventually," or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MSC undertakes no obligation to update such statements

CONTACT:

24/7 Market News
Editor@247marketnews.com

Send this to a friend

Hi, this may be interesting you: ! This is the link: https://www.247marketnews.com/company/kraig-biocraft-laboratories-inc/